Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective.

Autoantibodies Classification criteria Connective tissue diseases Systemic autoimmune rheumatic diseases

Journal

Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967

Informations de publication

Date de publication:
24 Aug 2024
Historique:
received: 28 06 2024
revised: 21 08 2024
accepted: 21 08 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 26 8 2024
Statut: aheadofprint

Résumé

Classification criteria of autoimmune rheumatic diseases are an important means to define homogenous groups of patients that can be compared across studies for clinical trials and research purposes. The measurement of autoantibodies is a relevant aspect in the definition of classification criteria, with a significant weight in the scores necessary to classify patients with autoimmune rheumatic diseases. The impact of autoantibodies has gradually increased over the years, contributing to the evolution and improvement of the classification criteria. However, these criteria often do not take into consideration how autoantibodies are measured, i.e. differences in diagnostic accuracy of the methods. This is a critical point especially when obsolete analytical methods that are no longer used in many clinical laboratories are taken into consideration. In this review we have critically examined assays and methods for the determination of autoantibodies that are (or could be) included among the classification criteria of autoimmune rheumatic diseases in light of more recent evidence and technology evolution.

Identifiants

pubmed: 39187223
pii: S1568-9972(24)00095-8
doi: 10.1016/j.autrev.2024.103604
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103604

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Nicola Bizzaro (N)

Laboratory of Clinical Pathology, Azienda Sanitaria Universitaria Integrata, Udine, Italy. Electronic address: nic.bizzaro@gmail.com.

Alessio Mazzoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Flow Cytometry Diagnostic Center and Immunotherapy Unit, Careggi University Hospital, Florence, Italy.

Teresa Carbone (T)

Immunopathology Laboratory, San Carlo Hospital, Potenza, Italy.

Luigi Cinquanta (L)

IRCCS SYNLAB SDN, Naples, Italy.

Danilo Villalta (D)

Immunology and Allergology, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Antonella Radice (A)

Autoimmunity and Allergology Laboratory, ASST Santi Paolo e Carlo, P.O. San Paolo Hospital, Milan, Italy.

Giampaola Pesce (G)

Autoimmunity Laboratory, IRCCS Ospedale Policlinico San Martino, Genua, Italy; Department of internal Medicine and Specialties (DiMI), University of Genua, Genua, Italy.

Mariangela Manfredi (M)

Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Florence, Italy.

Maria Infantino (M)

Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Florence, Italy.

Classifications MeSH